Drug name - Accrufer

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9802973 SHIELD TX Crystalline forms of ferric maltol
Oct, 2035

(13 years from now)

CN107001310B SHIELD TX Crystalline Form Of Iron Maltol
Oct, 2035

(13 years from now)

CN107001310A SHIELD TX Crystalline Form Of Iron Maltol
Oct, 2035

(13 years from now)

EP3160951A1 SHIELD TX Crystalline Forms Of Ferric Maltol
Oct, 2035

(13 years from now)

EP3160951B1 SHIELD TX Crystalline Forms Of Ferric Maltol
Oct, 2035

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9248148 SHIELD TX Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections Mar, 2031

(8 years from now)

US10179120 SHIELD TX Dosage regimen of ferric trimaltol Jan, 2035

(12 years from now)

Drugs and Companies using FERRIC MALTOL ingredient

Treatment: Method of treating iron deficiency

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
30MG IRON CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.